LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 40

Search options

  1. Article ; Online: Infection of Human Precision-Cut Lung Slices with the Influenza Virus.

    Sewald, Katherina / Danov, Olga

    Methods in molecular biology (Clifton, N.J.)

    2022  Volume 2506, Page(s) 119–134

    Abstract: Viral infections are common causes of asthma exacerbations. To model these processes ex vivo, human precision-cut lung slices (PCLSs) can be used. Here we describe the infection of human PCLSs with the human influenza virus. We then provide methods to ... ...

    Abstract Viral infections are common causes of asthma exacerbations. To model these processes ex vivo, human precision-cut lung slices (PCLSs) can be used. Here we describe the infection of human PCLSs with the human influenza virus. We then provide methods to quantify the virus and reveal its localization within infected PCLSs and study consequences of infection, including cell death and production of cytokines, chemokine, and mucus. We also describe the stimulation of PCLSs with immune mediators such as pro-inflammatory tumor necrosis factor α (TNF-α). These models are useful to investigate mechanisms of virally induced asthma exacerbations and study modes of action and efficacy of antiviral and/or anti-inflammatory drugs.
    MeSH term(s) Antiviral Agents/pharmacology ; Asthma/drug therapy ; Cytokines/metabolism ; Humans ; Influenza A Virus, H1N1 Subtype ; Influenza, Human ; Lung/metabolism ; Orthomyxoviridae Infections/drug therapy
    Chemical Substances Antiviral Agents ; Cytokines
    Language English
    Publishing date 2022-06-30
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-2364-0_9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A modified protocol for successful miRNA profiling in human precision-cut lung slices (PCLS).

    Niehof, Monika / Reamon-Buettner, Stella Marie / Danov, Olga / Hansen, Tanja / Sewald, Katherina

    BMC research notes

    2021  Volume 14, Issue 1, Page(s) 255

    Abstract: Objective: Human precision cut lung slices (PCLS) are widely used as an ex vivo model system for drug discovery and development of new therapies. PCLS reflect the functional heterogeneity of lung tissue and possess relevant lung cell types. We thus ... ...

    Abstract Objective: Human precision cut lung slices (PCLS) are widely used as an ex vivo model system for drug discovery and development of new therapies. PCLS reflect the functional heterogeneity of lung tissue and possess relevant lung cell types. We thus determined the use of PCLS in studying non-coding RNAs notably miRNAs, which are important gene regulatory molecules. Since miRNAs play key role as mediators of respiratory diseases, they can serve as valuable prognostic or diagnostic biomarkers, and in therapeutic interventions, of lung diseases. A technical limitation though is the vast amount of agarose in PCLS which impedes (mi)RNA extraction by standard procedures. Here we modified our recently published protocol for RNA isolation from PCLS to enable miRNA readouts.
    Results: The modified method relies on the separation of lysis and precipitation steps, and a clean-up procedure with specific magnetic beads. We obtained successfully quality miRNA amenable for downstream applications such as RTqPCR and whole transcriptome miRNA analysis. Comparison of miRNA profiles in PCLS with published data from human lung, identified all important miRNAs regulated in IPF, COPD, asthma or lung cancer. Therefore, this shows suitability of the method for analyzing miRNA targets and biomarkers in the valuable human PCLS model.
    MeSH term(s) Gene Expression Profiling ; Humans ; Lung ; Lung Diseases ; Lung Neoplasms ; MicroRNAs
    Chemical Substances MicroRNAs
    Language English
    Publishing date 2021-07-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2413336-X
    ISSN 1756-0500 ; 1756-0500
    ISSN (online) 1756-0500
    ISSN 1756-0500
    DOI 10.1186/s13104-021-05674-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue.

    Zimniak, Melissa / Kirschner, Luisa / Hilpert, Helen / Geiger, Nina / Danov, Olga / Oberwinkler, Heike / Steinke, Maria / Sewald, Katherina / Seibel, Jürgen / Bodem, Jochen

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 5890

    Abstract: To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this path and screened approved medications "off-label" against SARS-CoV-2. ... ...

    Abstract To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this path and screened approved medications "off-label" against SARS-CoV-2. Fluoxetine inhibited SARS-CoV-2 at a concentration of 0.8 µg/ml significantly in these screenings, and the EC50 was determined with 387 ng/ml. Furthermore, Fluoxetine reduced viral infectivity in precision-cut human lung slices showing its activity in relevant human tissue targeted in severe infections. Fluoxetine treatment resulted in a decrease in viral protein expression. Fluoxetine is a racemate consisting of both stereoisomers, while the S-form is the dominant serotonin reuptake inhibitor. We found that both isomers show similar activity on the virus, indicating that the R-form might specifically be used for SARS-CoV-2 treatment. Fluoxetine inhibited neither Rabies virus, human respiratory syncytial virus replication nor the Human Herpesvirus 8 or Herpes simplex virus type 1 gene expression, indicating that it acts virus-specific. Moreover, since it is known that Fluoxetine inhibits cytokine release, we see the role of Fluoxetine in the treatment of SARS-CoV-2 infected patients of risk groups.
    MeSH term(s) Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; COVID-19/virology ; Cell Line ; Cells, Cultured ; Fluoxetine/pharmacology ; Fluoxetine/therapeutic use ; Humans ; Lung/drug effects ; Lung/pathology ; Lung/virology ; SARS-CoV-2/drug effects ; Serotonin Uptake Inhibitors/pharmacology ; Serotonin Uptake Inhibitors/therapeutic use ; Virus Replication/drug effects
    Chemical Substances Antiviral Agents ; Serotonin Uptake Inhibitors ; Fluoxetine (01K63SUP8D)
    Language English
    Publishing date 2021-03-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-85049-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Rupintrivir reduces RV-induced T

    Danov, Olga / Lasswitz, Lisa / Obernolte, Helena / Hesse, Christina / Braun, Armin / Wronski, Sabine / Sewald, Katherina

    Respiratory research

    2019  Volume 20, Issue 1, Page(s) 228

    Abstract: Background: Antiviral drugs such as rupintrivir may have an immune-modulatory effect in experimentally induced allergic asthma with subsequent RV infection. We infected lung slices of house-dust mite (HDM)-sensitized asthmatic mice ex vivo with human ... ...

    Abstract Background: Antiviral drugs such as rupintrivir may have an immune-modulatory effect in experimentally induced allergic asthma with subsequent RV infection. We infected lung slices of house-dust mite (HDM)-sensitized asthmatic mice ex vivo with human rhinovirus (RV) and investigated the effect of the antiviral drug rupintrivir on RV-induced cytokine response in lung tissue of HDM-sensitized mice ex vivo.
    Methods: Mice were sensitized with HDM. Precision-cut lung slices (PCLS) were prepared from HDM-sensitized or non-sensitized mice. Lung slices were infected ex vivo with RV or RV together with rupintrivir. Modulation of immune responses was evaluated by cytokine secretion 48 h post infection.
    Results: In vivo HDM sensitization resulted in a T
    Conclusions: In summary, this study demonstrates that treatment with rupintrivir influences virus-induced IL-4 and IL-6 cytokine release under experimental conditions ex vivo.
    MeSH term(s) Animals ; Antiviral Agents/pharmacology ; Cytokines/antagonists & inhibitors ; Cytokines/immunology ; Female ; Interleukin-4/antagonists & inhibitors ; Interleukin-4/immunology ; Isoxazoles/pharmacology ; Lung/drug effects ; Lung/immunology ; Mice ; Mice, Inbred BALB C ; Organ Culture Techniques ; Pyroglyphidae/immunology ; Pyrrolidinones/pharmacology ; Rhinovirus ; Th2 Cells/drug effects ; Th2 Cells/immunology
    Chemical Substances Antiviral Agents ; Cytokines ; Isoxazoles ; Pyrrolidinones ; Interleukin-4 (207137-56-2) ; rupintrivir (RGE5K1Q5QW)
    Language English
    Publishing date 2019-10-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041675-1
    ISSN 1465-993X ; 1465-9921
    ISSN (online) 1465-993X
    ISSN 1465-9921
    DOI 10.1186/s12931-019-1175-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Competitive fitness of

    Cramer, Nina / Nawrot, Marie Luise / Wege, Lion / Dorda, Marie / Sommer, Charline / Danov, Olga / Wronski, Sabine / Braun, Armin / Jonigk, Danny / Fischer, Sebastian / Munder, Antje / Tümmler, Burkhard

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 992214

    Abstract: Chronic respiratory infections with the gram-negative ... ...

    Abstract Chronic respiratory infections with the gram-negative bacterium
    MeSH term(s) Animals ; Cystic Fibrosis/complications ; Cystic Fibrosis/microbiology ; Humans ; Lung/microbiology ; Mice ; Pseudomonas Infections/microbiology ; Pseudomonas aeruginosa/genetics
    Language English
    Publishing date 2022-08-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.992214
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection.

    Sauerhering, Lucie / Kuznetsova, Irina / Kupke, Alexandra / Meier, Lars / Halwe, Sandro / Rohde, Cornelius / Schmidt, Jörg / Morty, Rory E / Danov, Olga / Braun, Armin / Vadász, István / Becker, Stephan / Herold, Susanne

    American journal of respiratory and critical care medicine

    2022  Volume 205, Issue 8, Page(s) 964–968

    MeSH term(s) Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Cyclosporine/pharmacology ; Cyclosporine/therapeutic use ; Drug Evaluation, Preclinical ; Humans ; SARS-CoV-2
    Chemical Substances Antiviral Agents ; Cyclosporine (83HN0GTJ6D)
    Language English
    Publishing date 2022-04-10
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202108-1830LE
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties.

    Hempel, Tim / Elez, Katarina / Krüger, Nadine / Raich, Lluís / Shrimp, Jonathan H / Danov, Olga / Jonigk, Danny / Braun, Armin / Shen, Min / Hall, Matthew D / Pöhlmann, Stefan / Hoffmann, Markus / Noé, Frank

    Chemical science

    2021  Volume 12, Issue 38, Page(s) 12600–12609

    Abstract: SARS-CoV-2, the cause of the COVID-19 pandemic, exploits host cell proteins for viral entry into human lung cells. One of them, the protease TMPRSS2, is required to activate the viral spike protein (S). Even though two inhibitors, camostat and nafamostat, ...

    Abstract SARS-CoV-2, the cause of the COVID-19 pandemic, exploits host cell proteins for viral entry into human lung cells. One of them, the protease TMPRSS2, is required to activate the viral spike protein (S). Even though two inhibitors, camostat and nafamostat, are known to inhibit TMPRSS2 and block cell entry of SARS-CoV-2, finding further potent therapeutic options is still an important task. In this study, we report that a late-stage drug candidate, otamixaban, inhibits SARS-CoV-2 cell entry. We show that otamixaban suppresses TMPRSS2 activity and SARS-CoV-2 infection of a human lung cell line, although with lower potency than camostat or nafamostat. In contrast, otamixaban inhibits SARS-CoV-2 infection of precision cut lung slices with the same potency as camostat. Furthermore, we report that otamixaban's potency can be significantly enhanced by (sub-) nanomolar nafamostat or camostat supplementation. Dominant molecular TMPRSS2-otamixaban interactions are assessed by extensive 109 μs of atomistic molecular dynamics simulations. Our findings suggest that combinations of otamixaban with supplemental camostat or nafamostat are a promising option for the treatment of COVID-19.
    Language English
    Publishing date 2021-08-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 2559110-1
    ISSN 2041-6539 ; 2041-6520
    ISSN (online) 2041-6539
    ISSN 2041-6520
    DOI 10.1039/d1sc01494c
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Transcriptomic Analysis Reveals Priming of The Host Antiviral Interferon Signaling Pathway by Bronchobini

    Reamon-Buettner, Stella Marie / Niehof, Monika / Hirth, Natalie / Danov, Olga / Obernolte, Helena / Braun, Armin / Warnecke, Jürgen / Sewald, Katherina / Wronski, Sabine

    International journal of molecular sciences

    2019  Volume 20, Issue 9

    Abstract: Rhinovirus (RV) is the predominant virus causing respiratory tract infections. ... ...

    Abstract Rhinovirus (RV) is the predominant virus causing respiratory tract infections. Bronchobini
    MeSH term(s) Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Female ; Interferon Inducers/pharmacology ; Interferon Inducers/therapeutic use ; Interferons/metabolism ; Lung/drug effects ; Lung/metabolism ; Lung/virology ; Mice ; Mice, Inbred BALB C ; Picornaviridae Infections/drug therapy ; Picornaviridae Infections/immunology ; Picornaviridae Infections/virology ; Plant Extracts/pharmacology ; Plant Extracts/therapeutic use ; Rhinovirus/drug effects ; Rhinovirus/pathogenicity ; Signal Transduction ; Transcriptome
    Chemical Substances Antiviral Agents ; Interferon Inducers ; Plant Extracts ; Interferons (9008-11-1)
    Language English
    Publishing date 2019-05-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms20092242
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Bacterial vesicles block viral replication in macrophages via TLR4-TRIF-axis.

    Bierwagen, Jeff / Wiegand, Marie / Laakmann, Katrin / Danov, Olga / Limburg, Hannah / Herbel, Stefanie Muriel / Heimerl, Thomas / Dorna, Jens / Jonigk, Danny / Preußer, Christian / Bertrams, Wilhelm / Braun, Armin / Sewald, Katherina / Schulte, Leon N / Bauer, Stefan / Pogge von Strandmann, Elke / Böttcher-Friebertshäuser, Eva / Schmeck, Bernd / Jung, Anna Lena

    Cell communication and signaling : CCS

    2023  Volume 21, Issue 1, Page(s) 65

    Abstract: Gram-negative bacteria naturally secrete nano-sized outer membrane vesicles (OMVs), which are important mediators of communication and pathogenesis. OMV uptake by host cells activates TLR signalling via transported PAMPs. As important resident immune ... ...

    Abstract Gram-negative bacteria naturally secrete nano-sized outer membrane vesicles (OMVs), which are important mediators of communication and pathogenesis. OMV uptake by host cells activates TLR signalling via transported PAMPs. As important resident immune cells, alveolar macrophages are located at the air-tissue interface where they comprise the first line of defence against inhaled microorganisms and particles. To date, little is known about the interplay between alveolar macrophages and OMVs from pathogenic bacteria. The immune response to OMVs and underlying mechanisms are still elusive. Here, we investigated the response of primary human macrophages to bacterial vesicles (Legionella pneumophila, Klebsiella pneumoniae, Escherichia coli, Salmonella enterica, Streptococcus pneumoniae) and observed comparable NF-κB activation across all tested vesicles. In contrast, we describe differential type I IFN signalling with prolonged STAT1 phosphorylation and strong Mx1 induction, blocking influenza A virus replication only for Klebsiella, E.coli and Salmonella OMVs. OMV-induced antiviral effects were less pronounced for endotoxin-free Clear coli OMVs and Polymyxin-treated OMVs. LPS stimulation could not mimic this antiviral status, while TRIF knockout abrogated it. Importantly, supernatant from OMV-treated macrophages induced an antiviral response in alveolar epithelial cells (AEC), suggesting OMV-induced intercellular communication. Finally, results were validated in an ex vivo infection model with primary human lung tissue. In conclusion, Klebsiella, E.coli and Salmonella OMVs induce antiviral immunity in macrophages via TLR4-TRIF-signaling to reduce viral replication in macrophages, AECs and lung tissue. These gram-negative bacteria induce antiviral immunity in the lung through OMVs, with a potential decisive and tremendous impact on bacterial and viral coinfection outcome. Video Abstract.
    MeSH term(s) Humans ; Adaptor Proteins, Vesicular Transport ; Escherichia coli ; Extracellular Vesicles ; Macrophages ; Toll-Like Receptor 4 ; Virus Replication
    Chemical Substances Adaptor Proteins, Vesicular Transport ; TLR4 protein, human ; Toll-Like Receptor 4 ; TICAM1 protein, human
    Language English
    Publishing date 2023-03-28
    Publishing country England
    Document type Video-Audio Media ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2126315-2
    ISSN 1478-811X ; 1478-811X
    ISSN (online) 1478-811X
    ISSN 1478-811X
    DOI 10.1186/s12964-023-01086-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.

    Zmora, Pawel / Hoffmann, Markus / Kollmus, Heike / Moldenhauer, Anna-Sophie / Danov, Olga / Braun, Armin / Winkler, Michael / Schughart, Klaus / Pöhlmann, Stefan

    The Journal of biological chemistry

    2018  Volume 293, Issue 36, Page(s) 13863–13873

    Abstract: The influenza virus hemagglutinin (HA) facilitates viral entry into target cells. Cleavage of HA by host cell proteases is essential for viral infectivity, and the responsible enzymes are potential targets for antiviral intervention. The type II ... ...

    Abstract The influenza virus hemagglutinin (HA) facilitates viral entry into target cells. Cleavage of HA by host cell proteases is essential for viral infectivity, and the responsible enzymes are potential targets for antiviral intervention. The type II transmembrane serine protease (TTSP) TMPRSS2 has been identified as an HA activator in cell culture and in the infected host. However, it is less clear whether TMPRSS2-related enzymes can also activate HA for spread in target cells. Moreover, the activity of cellular serine protease inhibitors against HA-activating TTSPs is poorly understood. Here, we show that TMPRSS11A, another member of the TTSP family, cleaves and activates the influenza A virus (FLUAV) HA and the Middle East respiratory syndrome coronavirus spike protein (MERS-S). Moreover, we demonstrate that TMPRSS11A is expressed in murine tracheal epithelium, which is a target of FLUAV infection, and in human trachea, suggesting that the protease could support FLUAV spread in patients. Finally, we show that HA activation by the TMPRSS11A-related enzymes human airway tryptase and DESC1, but not TMPRSS11A itself, is blocked by the cellular serine protease inhibitor hepatocyte growth factor activator inhibitor type-1 (HAI-1). Our results suggest that TMPRSS11A could promote FLUAV spread in target cells and that HA-activating TTSPs exhibit differential sensitivity to blockade by cellular serine protease inhibitors.
    MeSH term(s) Animals ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism ; Hemagglutinins/metabolism ; Humans ; Influenza A virus/growth & development ; Membrane Glycoproteins ; Membrane Proteins/metabolism ; Mice ; Proteinase Inhibitory Proteins, Secretory/pharmacology ; Serine Endopeptidases/metabolism ; Serine Proteases/metabolism ; Spike Glycoprotein, Coronavirus/metabolism ; Virus Internalization
    Chemical Substances Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins ; Membrane Glycoproteins ; Membrane Proteins ; Proteinase Inhibitory Proteins, Secretory ; SPINT1 protein, human ; Spike Glycoprotein, Coronavirus ; Spint1 protein, mouse ; Serine Proteases (EC 3.4.-) ; TMPRSS11A protein, mouse (EC 3.4.-) ; Serine Endopeptidases (EC 3.4.21.-) ; TMPRSS2 protein, human (EC 3.4.21.-)
    Keywords covid19
    Language English
    Publishing date 2018-07-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.RA118.001273
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top